30 Tablets (Paroxetine 25 mg)
Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 46708-768
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 46708-768). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
30 Tablets (Paroxetine 37 5 mg)
This description is not available.*
Paroxetine-fig1.jpg (Paroxetine Fig1)
This text provides information on the interacting drugs (Pimozide, Desipramine, Propranolol, Digoxin, Phenytoin) and their dosages. It also mentions parameters like Cmax and AUC for each drug. Additionally, it includes details about fold change and 90% confidence intervals. Overall, this data may be used to assess the potential impacts of drug interactions on pharmacokinetics.*
Paroxetine-fig2.jpg (Paroxetine Fig2)
This text outlines the interacting drug PK fold change and 90% CI for various medications including Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam. It provides information on the dosages and Cmax (peak plasma concentration) as well as AUC (area under the curve) for each drug. Additionally, it mentions the change relative to a reference. This data is likely part of a pharmacokinetic study or analysis to evaluate the impact of these drugs on each other's plasma concentrations.*
Paroxetine-fig3.jpg (Paroxetine Fig3)
This is a list of population descriptions based on factors such as renal impairment, hepatic impairment, age, gender, and pharmacokinetic fold change with 90% confidence intervals. The information includes dosing recommendations for different levels of renal impairment and age groups, as well as the impact of gender on pharmacokinetics. The text also mentions changes in parameters such as Cmax, AUC, and Cmin relative to a reference value.*
Paroxetine-str.jpg (Paroxetine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
